MARCIA MCCULLOUGH: Open Payments
NPI 1730376435 · BELPRE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$485 in 27 payments from 12 companies in 2025. Trend: 2023 $175 · 2024 $282 · 2025 $485
Food & beverage: $470Education: $16
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $132 |
| Novartis Pharmaceuticals Corporation | 3 | $65 |
| SERVIER PHARMACEUTICALS LLC | 2 | $41 |
| ARRAY BIOPHARMA INC | 2 | $41 |
| Merck Sharp & Dohme LLC | 2 | $40 |
| Celgene Corporation | 2 | $38 |
| SpringWorks Therapeutics, Inc. | 1 | $28 |
| Aveo Pharmaceuticals, Inc. | 1 | $23 |
| Gilead Sciences, Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
Products named: XTANDI, PLUVICTO, Tibsovo, KEYTRUDA, REBLOZYL, ELREXFIO, OGSIVEO, KISQALI.
Industry payments across OH — which companies pay providers there.
